EDWARDS JEFFREY L — SEC Form 4 filings
SEC reporting owner CIK 1190642. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-02 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIO-RAD LABORATORIES, INC. | Director | 3 | — | — | 7 |
| KYNTRA BIO, INC. (KYNB) | Director | 3 | — | — | 3 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Director | 2 | — | — | 3 |
| Clearside Biomedical, Inc. (CLSD) | Director | 1 | — | — | 1 |
Form 4 filings — EDWARDS JEFFREY L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | KYNTRA BIO, INC. (KYNB) | Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | BIO-RAD LABORATORIES, INC. | Option exercise (M): 407 @ $0 · Grant/award (A): 369 (derivative) @ $0 · Option exercise (M): 407 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | FIBROGEN INC (FGEN) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-04-24 | 4 | BIO-RAD LABORATORIES, INC. | Option exercise (M): 308 @ $0 · Grant/award (A): 407 (derivative) @ $0 · Option exercise (M): 308 (derivative) @ $0 | EDGAR |
| 2024-09-10 | 4 | BIO-RAD LABORATORIES, INC. | Grant/award (A): 308 (derivative) @ $0 | EDGAR |
| 2024-07-10 | 4 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/award (A): 30,000 | EDGAR |
| 2024-06-21 | 4 | Clearside Biomedical, Inc. (CLSD) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | FIBROGEN INC (FGEN) | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Option exercise (M): 9,554 · Option exercise (M): 9,554 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1190642 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →